Remember
 
+
 
+
 Do You Know the Most Important and Timely Stock Plays During the Trading Week? View Our Power Rankings.
 
anonusers Placed a 'Sell' Sentiment on UNVC1 day ago
anonusers Placed a 'Buy' Sentiment on HOME3 days ago
anonusers Placed a 'Sell' Sentiment on WBA3 days ago
russurban Placed a 'Buy' Sentiment on VXRT3 days ago
russurban Placed a 'Buy' Sentiment on OTLK3 days ago
russurban Followed OTLK3 days ago
stockarticles Placed a 'Buy' Sentiment on BB3 days ago
stockarticles Followed BB3 days ago
stockarticles Placed a 'Buy' Sentiment on SNAPMore than a week ago
 
Most Discussed Stocks through Posts and Reactions on SpeculatingStocks  VXRT  •  OTLK  •  PINS  •  BB  •  TWTR  •  CGC  •  ARCI  •  LULU  •  SNAP  •  IRBT
     
 

June 29, 2004

SpeculatingStocks.com Stock Pick: Peregrine Pharmaceuticals, Inc. (PPHM)

Stock Price: $0.95


Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of products under development directed towards the treatment of cancer, viruses and other diseases. The company is in the process of initiating patient enrollment in a Tarvacin(TM) clinical trial for the treatment of all solid cancers and in a Cotara® clinical trial for the treatment of brain cancer.

The company recently received a $6.7 million private placement on June 23rd. The funding will be used to further the three current clinical trials and to study Tarvacin(TM)'s full potential.

PPHM is now at the bottom of its range and a solid buy. PPHM has been below $1.00 two other times this year and each time has jumped above $1.60.

If Tarvacin lives up to its potential, it could become a blockbuster cancer drug.

 
     
Untitled Document